Neoplasm Metastasis
|
0.040 |
Biomarker
|
phenotype |
BEFREE |
M-phase phosphoprotein 8 promotes gastric cancer growth and metastasis via p53/Bcl-2 and EMT-related signaling pathways.
|
31692032 |
2020 |
Neoplasm Metastasis
|
0.040 |
Biomarker
|
phenotype |
BEFREE |
These results indicate that MPP8 plays an important role in the proliferation and metastasis of CRC cells and suggest that silencing of MPP8 may be an effective therapeutic approach for the treatment of CRC.
|
27174009 |
2017 |
Neoplasm Metastasis
|
0.040 |
PosttranslationalModification
|
phenotype |
BEFREE |
We recently revealed that MPP8 couples H3K9 methylation and DNA methylation for E-cadherin gene silencing and promotes tumor cell migration, invasion, and EMT.
|
25870236 |
2015 |
Neoplasm Metastasis
|
0.040 |
AlteredExpression
|
phenotype |
BEFREE |
Together, our results suggest a model by which MPP8 recognizes methyl-H3K9 marks and directs DNA methylation to repress tumour suppressor gene expression and, in turn, has an important function in epithelial-to-mesenchymal transition and metastasis.
|
20871592 |
2010 |
Neoplasms
|
0.020 |
AlteredExpression
|
group |
BEFREE |
Furthermore, MPP8 overexpression in tumor tissues was marginally associated with a poor prognosis, with a significant relationship between MPP8 overexpression and prognosis among patients with poorly differentiated gastric cancer.
|
31692032 |
2020 |
Tumor Cell Invasion
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
Inhibition of MPP8 in these cells significantly suppressed proliferation and colony formation, promoted apoptosis, and repressed invasion.
|
31692032 |
2020 |
Neoplasms
|
0.020 |
PosttranslationalModification
|
group |
BEFREE |
Together, our results suggest a model by which MPP8 recognizes methyl-H3K9 marks and directs DNA methylation to repress tumour suppressor gene expression and, in turn, has an important function in epithelial-to-mesenchymal transition and metastasis.
|
20871592 |
2010 |
Tumor Cell Invasion
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
Methyl-H3K9-binding protein MPP8 mediates E-cadherin gene silencing and promotes tumour cell motility and invasion.
|
20871592 |
2010 |
Malignant neoplasm of stomach
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Furthermore, MPP8 overexpression in tumor tissues was marginally associated with a poor prognosis, with a significant relationship between MPP8 overexpression and prognosis among patients with poorly differentiated gastric cancer.
|
31692032 |
2020 |
Stomach Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
The main issue of this study is to demonstrate whether M-phase phosphoprotein 8 (MPP8) affect gastric tumor growth and metastasis.
|
31692032 |
2020 |
Stomach Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Furthermore, MPP8 overexpression in tumor tissues was marginally associated with a poor prognosis, with a significant relationship between MPP8 overexpression and prognosis among patients with poorly differentiated gastric cancer.
|
31692032 |
2020 |
Malignant Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
M-phase phosphoprotein 8 (MPP8) is reported to be closely implicated in cancer initiation and progression.
|
29412790 |
2018 |
Non-Small Cell Lung Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Compared with the human lung fibroblasts, the elevated gene expression of MPP8 was also detected in the human NSCLC cell lines including NCI-H23 and NCI-H1299.
|
29412790 |
2018 |
Primary malignant neoplasm
|
0.010 |
Biomarker
|
group |
BEFREE |
M-phase phosphoprotein 8 (MPP8) is reported to be closely implicated in cancer initiation and progression.
|
29412790 |
2018 |
Colorectal Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
These results indicate that MPP8 plays an important role in the proliferation and metastasis of CRC cells and suggest that silencing of MPP8 may be an effective therapeutic approach for the treatment of CRC.
|
27174009 |
2017 |
Tumor Progression
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
Following characterization demonstrates that MPP8 targets the E-cadherin gene promoter and modulates the expression of this key regulator of cell behaviour and tumour progression through its methyl-H3K9 binding.
|
20871592 |
2010 |